These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 29890734

  • 1. The Impact of the Nitric Oxide (NO)/Soluble Guanylyl Cyclase (sGC) Signaling Cascade on Kidney Health and Disease: A Preclinical Perspective.
    Krishnan SM, Kraehling JR, Eitner F, Bénardeau A, Sandner P.
    Int J Mol Sci; 2018 Jun 09; 19(6):. PubMed ID: 29890734
    [Abstract] [Full Text] [Related]

  • 2. Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
    Breitenstein S, Roessig L, Sandner P, Lewis KS.
    Handb Exp Pharmacol; 2017 Jun 09; 243():225-247. PubMed ID: 27900610
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Homogeneous single-label cGMP detection platform for the functional study of nitric oxide-sensitive (soluble) guanylyl cyclases and cGMP-specific phosphodiesterases.
    Kopra K, Sharina I, Martin E, Härmä H.
    Sci Rep; 2020 Oct 15; 10(1):17469. PubMed ID: 33060787
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase.
    Benza RL, Grünig E, Sandner P, Stasch JP, Simonneau G.
    Eur Respir Rev; 2024 Jan 31; 33(171):. PubMed ID: 38508664
    [Abstract] [Full Text] [Related]

  • 7. Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence.
    Sandner P, Stasch JP.
    Respir Med; 2017 Jan 31; 122 Suppl 1():S1-S9. PubMed ID: 28341058
    [Abstract] [Full Text] [Related]

  • 8. From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulators.
    Sandner P.
    Biol Chem; 2018 Jun 27; 399(7):679-690. PubMed ID: 29604206
    [Abstract] [Full Text] [Related]

  • 9. BAY58-2667 Activates Different Soluble Guanylyl Cyclase Species by Distinct Mechanisms that Indicate Its Principal Target in Cells is the Heme-Free Soluble Guanylyl Cyclase-Heat Shock Protein 90 Complex.
    Dai Y, Stuehr DJ.
    Mol Pharmacol; 2023 May 27; 103(5):286-296. PubMed ID: 36868790
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Erectile Dysfunction in Heme-Deficient Nitric Oxide-Unresponsive Soluble Guanylate Cyclase Knock-In Mice.
    Decaluwé K, Pauwels B, Boydens C, Thoonen R, Buys ES, Brouckaert P, Van de Voorde J.
    J Sex Med; 2017 Feb 27; 14(2):196-204. PubMed ID: 28161078
    [Abstract] [Full Text] [Related]

  • 13. Novel soluble guanylyl cyclase activators increase glomerular cGMP, induce vasodilation and improve blood flow in the murine kidney.
    Stehle D, Xu MZ, Schomber T, Hahn MG, Schweda F, Feil S, Kraehling JR, Eitner F, Patzak A, Sandner P, Feil R, Bénardeau A.
    Br J Pharmacol; 2022 Jun 27; 179(11):2476-2489. PubMed ID: 34096053
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure.
    Triposkiadis F, Xanthopoulos A, Skoularigis J, Starling RC.
    Heart Fail Rev; 2022 Nov 27; 27(6):1991-2003. PubMed ID: 35437713
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic Targeting of the Soluble Guanylate Cyclase.
    Makrynitsa GI, Zompra AA, Argyriou AI, Spyroulias GA, Topouzis S.
    Curr Med Chem; 2019 Nov 27; 26(15):2730-2747. PubMed ID: 30621555
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A primer for measuring cGMP signaling and cGMP-mediated vascular relaxation.
    Straub AC, Beuve A.
    Nitric Oxide; 2021 Dec 01; 117():40-45. PubMed ID: 34601102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.